| BEHAB | Brain-enriched hyaluronan-binding protein |
| CD44 | Cluster of differentiation 44 |
| CD280 | Endo180 |
| CHI3L1 | Chitinase-3-like protein 1 |
| CNS | Central nervous system |
| COL1A2 | Collagen alpha-2(I) chain |
| CSPG | Chondroitin sulfate proteoglycan |
| ECM | Extracellular matrix |
| ED-A | Extra domain A |
| ED-B | Extra domain B |
| EGFR | Epidermal growth factor receptor |
| FAK | Focal adhesion kinase |
| GAG | Glycosaminoglycan |
| GBM | Glioblastoma |
| HSPG | Heparan sulfate proteoglycan |
| IL-1 | Interleukin-1 |
| LAR | Leukocyte common antigen-related |
| MEK/ERK | Mitogen-activated protein kinase/extracellular signal-regulated kinase |
| MMP | Matrix metalloproteinase |
| NFkB | Nuclear factor kappa-light-chain enhancer of activated B cells |
| N-CAM | Neural cell adhesion molecule |
| PAI-1 | Plasminogen activator inhibitor-1 |
| P4HA2 | Prolyl-4-hydroxylase subunit 2 |
| PRISMA-P | Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols |
| PRO | Periostin |
| RHAMM | Receptor for hyaluronan-mediated motility |
| siRNA | Small interfering RNA |
| TGF-β | Transforming growth factor beta |
| TME | Tumor microenvironment |
| uPA | Urokinase-type plasminogen activator |
| uPAR | Urokinase-type plasminogen activator receptor |